## ROL: Rollins, Inc. - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_10 -2.6% below STRENGTH zone (3.0-6.0%); PEG 3.96 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.6% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($58.32)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 8, Bearish: 0)

**1. ROL SEC Filings - Rollins 10-K, 10-Q, 8-K Forms**
- Source: Stock Titan | 20251204T140923 | Neutral | Relevance: 100%
- This page on Stock Titan provides comprehensive access to Rollins Inc. (ROL) SEC filings, including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms. It features AI-powered summaries of these documents, real-time EDGAR updates, and contextual analytics to help investors understand the company's financial performance and insider activity. The page highlights several recent filings, including secondary offerings, Q3 revenue growth, and insider transactions.

**2. Bernstein reiterates Outperform rating on Rollins stock at $70 price target**
- Source: Investing.com | 20251202T081700 | Bullish | Relevance: 100%
- Bernstein has reiterated its Outperform rating and a $70.00 price target on Rollins (NYSE:ROL), considering it a top pick among waste companies despite its premium valuation. The firm highlights CFO Ken Krause's cost-cutting expertise from his previous role and observes strong YTD stock returns. Investor discussions also covered a recent share sale by the Rollins family as well as potential shifts with competitor Rentokil.

**3. Bernstein reiterates Outperform rating on Rollins stock at $70 price target**
- Source: Investing.com | 20251202T081700 | Bullish | Relevance: 100%
- Bernstein has reiterated its Outperform rating on Rollins (NYSE:ROL) with a $70 price target, highlighting the company as a top pick among waste companies despite its premium valuation. The firm noted CFO Ken Krause's unrecognized background in cost reduction as a key factor and addressed investor discussions around the Rollins family's share sale and Rentokil's potential turnaround. Rollins' stock has shown strong returns year-to-date and is trading near its 52-week high, reflecting continued investor confidence amidst ongoing leadership changes and modernization efforts.

**4. Rollins Stock Attracts Major Institutional Interest and Bullish Price Target**
- Source: Primary Ignition | 20251204T111143 | Bullish | Relevance: 100%
- Rollins Inc. is gaining significant attention from Wall Street due to substantial buying activity from institutional investors, including Norges Bank, and a bullish "Outperform" rating with a $70 price target from Bernstein. Despite a premium valuation, the pest control giant demonstrated strong financial performance with 12% revenue growth and increased net income in its latest quarter. All eyes are on the upcoming December 9th analyst day, where management is expected to detail the strategic roadmap and updates on the critical "BOSS" system, which could drive the stock toward its new target.

**5. Mackenzie Financial Corp Increases Position in Rollins, Inc. $ROL**
- Source: MarketBeat | 20251202T115150 | Bullish | Relevance: 100%
- Mackenzie Financial Corp increased its stake in Rollins, Inc. (NYSE: ROL) by 10.8%, bringing its total holdings to 954,142 shares valued at $53.8 million. This increase contributes to institutional investors owning approximately 51.8% of the company. Rollins recently reported strong quarterly earnings, beating analyst expectations with $0.35 EPS and $1.03 billion in revenue, and subsequently boosted its quarterly dividend.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-12 | Bernstein | $70 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-12 | Bernstein | init | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 7 ($3296.08M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 24.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 4 |

**Top Holders:**
- Vanguard Group Inc: 7.6% (+4.2%)
- Blackrock Inc.: 6.0% (+1.2%)
- State Street Corpora: 2.5% (+1.4%)
- Kayne Anderson Rudni: 2.0% (-2.8%)
- Geode Capital Manage: 2.0% (+1.7%)

### Key Risks

1. Heavy insider selling: $3296M sold (7 transactions in 90 days).
2. Valuation stretched: PEG 4.0x requires aggressive growth execution.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 3.96 signals overvaluation risk, limited margin of safety. Forward P/E 47.2x stretched relative to 12% growth. Quality metrics strong (ROE 36%, ROA 15%). Insider selling cluster ($3296.1M in 90 days), potential headwind. Institutional flow bullish (5 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $29.2B |
| Beta | 0.79 |
| 52W Range | $45.34 - $61.84 |
| Short Interest | 3.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.96 |
| Forward P/E | 47.2 |
| Current P/E | 52.9 |
| YoY Growth | 12.1% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from -0.0% to -2.6% (-2.6% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 5.6pp (needs >3.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 58. OFD pattern: -STL (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -2.60% (CS: 24) | Weak |
| RSI_14 | 57.9 | Neutral |
| MACD Histogram | 0.03 | Bullish |
| vs SMA20 | 1.013x | Above |
| vs SMA50 | 1.037x | Above |
| vs SMA200 | 1.073x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $60.34
- **Stop Loss:** $58.32 (3.3% risk)
- **Target:** $62.36 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 495
- **Position Value:** $29,868.30
- **Portfolio %:** 29.87%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at 15.78 indicates calm conditions but breadth at 53% suggests narrow participation. Fed policy remains neutral with 42 days to next meeting, supporting steady positioning with sector selectivity.*

### Earnings

**Next:** 2026-02-18 (Est: $0.27)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.33 | $0.35 | +6.3% |
| 2025Q2 | $0.30 | $0.30 | -0.7% |
| 2025Q1 | $0.22 | $0.22 | +1.3% |
| 2024Q4 | $0.23 | $0.23 | -0.8% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*